Genes4Life - Genelist
Carrier Screening Test
# | Condition | Gene |
---|---|---|
1 | 17-Beta-Hydroxysteroid Dehydrogenase Deficiency, Type III | HSD17B3 |
2 | 2-Methylbutyryl-CoA Dehydrogenase Deficiency | ACADSB |
3 | 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasi | CYP21A2 |
4 | 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency | HMGCL |
5 | 3-Hydroxyacyl-CoA Dehydrogenase Deficiency | HADH |
6 | 3-Hydroxyisobutryl-CoA Hydrolase Deficiency | HIBCH |
7 | 3-Methylcrotonyl-CoA Carboxylase 1 Deficiency | MCCC1 |
8 | 3-Methylcrotonyl-CoA Carboxylase 2 Deficiency | MCCC2 |
A | ||
9 | AICA-Ribosiduria | ATIC |
10 | Abetalipoproteinemia | MTTP |
11 | Achalasia-Addisonianism-Alacrimia Syndrome | AAAS |
12 | Achondrogenesis, Type 1B | SLC26A2 |
13 | Achromatopsia CNGB3-Related | CNGB3 |
14 | Acrodermatitis Enteropathica | SLC39A4 |
15 | Acute Infantile Liver Failure, TRMU-Related | TRMU |
16 | Adenosine Deaminase Deficiency | ADA |
17 | Adrenal Hyperplasia | HSD3B2 |
18 | Adrenal Hyperplasia V | CYP17A1 |
19 | AdrenoleukoDystrophy | ABCD1 |
20 | Aicardi-Goutieres Syndrome 1 | TREX1 |
21 | Aicardi-Goutieres syndrom (AGS) | RNASEH2A |
22 | Aicardi-Goutieres syndrom (AGS) | RNASEH2B |
23 | Aicardi-Goutieres syndrom (AGS) | RNASEH2C |
24 | Aicardi-Goutieres syndrom (AGS) | SAMHD1 |
25 | Albinism, Oculocutaneous, Type I | TYR |
26 | Albinism, Oculocutaneous, Type II | OCA2 |
27 | Albinism, Oculocutaneous, Type III | TYRP1 |
28 | Albinism, Oculocutaneous, Type IV | SLC45A2 |
29 | Albinism, Oculocutaneous, Type VII | LRMDA |
30 | Alkaptonuria | HGD |
31 | Alpers Syndrome | POLG |
32 | Alpha thalassemia | HBA1 |
33 | Alpha thalassemia | HBA2 |
34 | Alpha-Mannosidosis | MAN2B1 |
35 | Alpha-Methylacetoacetic Aciduria | ACAT1 |
36 | Alpha-N-Acetylgalactosaminidase Deficiency, Type 1 (Schindler Disease) | NAGA |
37 | Alport Syndrome, COL4A3-Related | COL4A3 |
38 | Alport Syndrome, COL4A4-Related | COL4A4 |
39 | Alport Syndrome, COL4A5-Related | COL4A5 |
40 | Alstrom Syndrome | ALMS1 |
41 | Amish Infantile Epilepsy Syndrome | ST3GAL5 |
42 | Argininosuccinic Aciduria | ASL |
43 | Aromatic L-amino acid Decarboxylase Deficiency | DDC |
44 | Arthrogryposis, Mental Retardation and Seizures | SLC35A3 |
45 | Arthrogryposis, Renal Dysfunction and Cholestasis 1 | VPS33B |
46 | Asparagine Synthetase Deficiency | ASNS |
47 | Aspartylglycosaminuria | AGA |
48 | Ataxia | TTPA |
49 | Ataxia Telangiectasia | ATM |
B | ||
50 | Bardet-Biedl Syndrome 1 | BBS1 |
51 | Bardet-Biedl Syndrome 10 | BBS10 |
52 | Bardet-Biedl Syndrome 11 | TRIM32 |
53 | Bardet-Biedl Syndrome 12 | BBS12 |
54 | Bardet-Biedl Syndrome 13 / Meckel-Gruber Syndrome 1 / Joubert Syndrome 28 | MKS1 |
55 | Bardet-Biedl Syndrome 16 | SDCCAG8 |
56 | Bardet-Biedl Syndrome 17 | LZTFL1 |
57 | Bardet-Biedl Syndrome 18 | BBIP1 |
58 | Bardet-Biedl Syndrome 19 | IFT27 |
59 | Bardet-Biedl Syndrome 2 | BBS2 |
60 | Bardet-Biedl Syndrome 20 | IFT172 |
61 | Bardet-Biedl Syndrome 3 | ARL6 |
62 | Bardet-Biedl Syndrome 4 | BBS4 |
63 | Bardet-Biedl Syndrome 5 | BBS5 |
64 | Bardet-Biedl Syndrome 6 | MKKS |
65 | Bardet-Biedl Syndrome 7 | BBS7 |
66 | Bardet-Biedl Syndrome 8 | TTC8 |
67 | Bardet-Biedl Syndrome 9 | BBS9 |
68 | Bardet-Biedl syndrome 21 / Cone-Rod Dystrophy 16 / Retinitis Pigmentosa 64 | C8orf37 |
69 | Bartter Syndrome | BSND |
70 | Bernard-Soulier Syndrome, Type A1 | GP1BA |
71 | Bernard-Soulier Syndrome, Type C | GP9 |
72 | Beta-Thalassemia | HBB |
73 | Bile Acid Synthesis Defect, Type 4 | AMACR |
74 | Biotinidase Deficiency | BTD |
75 | Blomstrand Chondrodysplasia | PTH1R |
76 | Bloom Syndrome | BLM |
77 | Brittle Cornea Syndrome 1 | ZNF469 |
C | ||
78 | CPT II Deficiency, Infantile | CPT2 |
79 | Canavan Disease | ASPA |
80 | Carbamoyl-Phosphate Synthetase 1 Deficiency | CPS1 |
81 | Carnitine Deficiency | SLC22A5 |
82 | Carnitine Palmitoyltransferase Deficiency, Type 1A | CPT1A |
83 | Carnitine-acylcarnitine Translocase Deficiency | SLC25A20 |
84 | Carpenter Syndrome | RAB23 |
85 | Cartilage-Hair Hypoplasia | RMRP |
86 | Cerebellar Hypoplasia and Mental Retardation | VLDLR |
87 | Cerebellar Hypoplasia, Type 1 | EXOSC3 |
88 | Cerebral Creatine Deficiency Syndrome 2 | GAMT |
89 | Cerebral Dysgenesis, Neuropathy, Ichthyosis and Palmoplantar Keratoderma Syndrome | SNAP29 |
90 | Cerebrotendinous Xanthomatosis | CYP27A1 |
91 | Ceroid Lipofuscinosis | MFSD8 |
92 | Ceroid Lipofuscinosis | CLN8 |
93 | Charcot-Marie-Tooth Disease, Type 2B1 | LMNA |
94 | Charcot-Marie-Tooth Disease, Type 2EE | MPV17 |
95 | Charcot-Marie-Tooth Disease, Type 2S | IGHMBP2 |
96 | Charcot-Marie-Tooth Disease, Type 4F | PRX |
97 | Charcot-Marie-Tooth Disease, Type 4H | FGD4 |
98 | Choreoacanthocytosis | VPS13A |
99 | Choroideremia | CHM |
100 | Chronic Granulomatous Disease 1 | NCF1 |
101 | Chronic Granulomatous Disease 4 | CYBA |
102 | Ciliary Dyskinesia, Type 1 | DNAI1 |
103 | Ciliary Dyskinesia, Type 9 | DNAI2 |
104 | Citrin Deficiency | SLC25A13 |
105 | Citrullinemia, Type 1 | ASS1 |
106 | Classical homocystinuria | CBS |
107 | Coenzyme Q10 Deficiency, Type 2 | PDSS1 |
108 | Coenzyme Q10 Deficiency, Type 4 | COQ8A |
109 | Cohen Syndrome | VPS13B |
110 | Cold-induced Sweating Syndrome 1 | CRLF1 |
111 | Colobomatous Microphthalmia | STRA6 |
112 | Combined Malonic and Methylmalonic Aciduria | ACSF3 |
113 | Combined Oxidative Phosphorylation Deficiency 1 | GFM1 |
114 | Combined Oxidative Phosphorylation Deficiency 3 | TSFM |
115 | Cone-Rod Dystrophy and Hearing Loss 2 | CEP250 |
116 | Congenital Adrenal Hyperplasia, 11-b hydroxylase | CYP11B1 |
117 | Congenital Amegakaryocytic Thrombocytopenia | MPL |
118 | Congenital Disorder of Glycosylation, Type 1a | PMM2 |
119 | Congenital Disorder of Glycosylation, Type II | B4GALT1 |
120 | Congenital Disorder of Glycosylation, Type IIb | MOGS |
121 | Congenital Disorder of Glycosylation, Type Ib | MPI |
122 | Congenital Disorder of Glycosylation, Type Ic | ALG6 |
123 | Congenital Disorder of Glycosylation, Type Ie | DPM1 |
124 | Congenital Disorder of Glycosylation, Type Iia | MGAT2 |
125 | Congenital Disorder of Glycosylation, Type Iic | SLC35C1 |
126 | Congenital Disorder of Glycosylation, Type Iif | SLC35A1 |
127 | Congenital Disorder of Glycosylation, Type Ik | ALG1 |
128 | Congenital Erythropoietic Porphyria | UROS |
129 | Congenital Hypothyroidism | TSHR |
130 | Congenital Insensitivity to pain with Anhidrosis | NTRK1 |
131 | Congenital Myasthenic Syndrome 4B | CHRNE |
132 | Congenital Non-Bullous Ichthyosiform Erythroderma | ABCA12 |
133 | Congenital Thrombotic Thrombocytopenic Purpura | ADAMTS13 |
134 | Corneal Endothelial Dystrophy | SLC4A11 |
135 | Corpus Callosum Agenesis-Neuronopathy Syndrome | SLC12A6 |
136 | Costeff Syndrome | OPA3 |
137 | Cutis Laxa Classic, Type 2 | ATP6V0A2 |
138 | Cutis Laxa, Type IA | FBLN5 |
139 | Cutis Laxa, Type IB | EFEMP2 |
140 | Cystic Fibrosis | CFTR |
141 | Cystinosis | CTNS |
142 | Cystinuria | SLC3A1 |
D | ||
143 | Deafness 53 | COL11A2 |
144 | Deafness 77 | LOXHD1 |
145 | Desmosterolosis | DHCR24 |
146 | Dihydropyrimidine Dehydrogenase Deficiency | DPYD |
147 | Distal Renal Tubular Acidosis | ATP6V1B1 |
148 | Donnai-Barrow Syndrome | LRP2 |
149 | Dopa-Responsive Dystonia | TH |
150 | Duchenne Muscular Dystrophy | DMD |
151 | Dysplasminogenemia | PLG |
E | ||
152 | Ehlers-Danlos Syndrome, Cardiac Valvular Type | COL1A2 |
153 | Ehlers-Danlos Syndrome, Dermatosparaxis Type | ADAMTS2 |
154 | Ellis-van Creveld Syndrome | EVC2 |
155 | Ellis-van Creveld Syndrome | EVC |
156 | Emery-Dreifuss Muscular Dystrophy | FHL1 |
157 | Emphysema | SERPINA1 |
158 | Epidermolysis Bullosa, Type 1 | LAMB3 |
159 | Epidermolysis Bullosa, Type 2 | LAMA3 |
160 | Epidermolysis Bullosa, Type 3 | LAMC2 |
161 | Epidermolysis Bullosa, Type 4 | COL17A1 |
162 | Epidermolysis Bullosa, Type 5 | ITGB4 |
163 | Epidermolysis Bullosa, Type 6 | ITGA6 |
164 | Ethylmalonic Encephalopathy | ETHE1 |
F | ||
165 | Fabry Disease | GLA |
166 | Factor IX Deficiency | F9 |
167 | Factor VIII Deficiency | F8 |
168 | Factor XI Deficiency | F11 |
169 | Familial Chloride Diarrhea | SLC26A3 |
170 | Familial Dysautonomia | ELP1 |
171 | Familial Hyperinsulinemic Hypoglycemia | ABCC8 |
172 | Familial Hyperinsulinism | KCNJ11 |
173 | Familial Mediterranean Fever | MEFV |
174 | Fanconi Anemia, Group C | FANCC |
175 | Fanconi Anemia, Group G | FANCG |
176 | Fanconi Anemia, Troup A | FANCA |
177 | Fetal Akinesia Deformation Sequence | RAPSN |
178 | Fragile X Syndrome | FMR1 |
179 | French Canadian Type of Leigh Syndrome | LRPPRC |
180 | Fucosidosis | FUCA1 |
181 | Fuhrmann Syndrome | WNT7A |
182 | Fumarase Deficiency | FH |
G | ||
183 | GRACILE Syndrome | BCS1L |
184 | Galactokinase Deficiency, Type II | GALK1 |
185 | Galactosemia | GALT |
186 | Gaucher Disease | GBA |
187 | Gitelman Syndrome | SLC12A3 |
188 | Glutaric Acidemia IIA | ETFA |
189 | Glutaric Acidemia IIC | ETFDH |
190 | Glutaric Acidemia, Type 1 | GCDH |
191 | Glycine Encephalopathy | GLDC |
192 | Glycogen Storage Disease VII | PFKM |
193 | Glycogen Storage Disease, Type 1A | G6PC1 |
194 | Glycogen Storage Disease, Type 2 (Pompe Disease) | GAA |
195 | Glycogen Storage Disease, Type 3 | AGL |
196 | Glycogen Storage Disease, Type 4 | GBE1 |
197 | Glycogen Storage Disease, Type B | SLC37A4 |
198 | Greenberg Skeletal Dysplasia | LBR |
199 | Griscelli Syndrome, Type 1 | MYO5A |
200 | Griscelli Syndrome, Type 2 | RAB27A |
201 | Gyrate Atrophy of Choroid and Retina | OAT |
H | ||
202 | Hemochromatosis, Type 2 | HJV |
203 | Hemochromatosis, Type 3 | TFR2 |
204 | Hepatic Venoocclusive Disease with Immunodeficiency | SP110 |
205 | Hereditary Fructose Intolerance | ALDOB |
206 | Hermansky-Pudlak Syndrome 1 | HPS1 |
207 | Holocarboxylase Synthetase Deficiency | HLCS |
208 | Homocystinuria | MTHFR |
209 | Homocystinuria-Megaloblastic Anemia | MTRR |
210 | Hunter Syndrome | IDS |
211 | Hurler syndrome | IDUA |
212 | Hyaline Fibromatosis Syndrome | ANTXR2 |
213 | Hydrolethalus Syndrome | HYLS1 |
214 | Hyperoxaluria, Type I | AGXT |
215 | Hyperoxaluria, Type II | GRHPR |
216 | Hyperoxaluria, Type III | HOGA1 |
217 | Hyperphenylalaninemia | PTS |
218 | Hypoaldosteronism, CMO I Deficiency | CYP11B2 |
219 | Hypohidrotic Ectodermal Dysplasia | EDA |
220 | Hypomyelinating leukodystrophy 12 | VPS11 |
221 | Hypophosphatasia | ALPL |
I | ||
222 | Immunodeficiency-Centromeric Instability-Facial Anomalies Syndrome 1 | DNMT3B |
223 | Infantile Striatonigral Degeneration | NUP62 |
224 | Insulin-Like Growth Factor I Deficiency | IGF1 |
225 | Isovaleric Acidemia | IVD |
J | ||
226 | Jervell and Lange-Nielsen Syndrome | KCNQ1 |
227 | Joubert Syndrome 1 | INPP5E |
228 | Joubert Syndrome 12 | KIF7 |
229 | Joubert Syndrome 13 | TCTN1 |
230 | Joubert Syndrome 14 | TMEM237 |
231 | Joubert Syndrome 15 | CEP41 |
232 | Joubert Syndrome 16 | TMEM138 |
233 | Joubert Syndrome 17 | CPLANE1 |
234 | Joubert Syndrome 18 | TCTN3 |
235 | Joubert Syndrome 2 | TMEM216 |
236 | Joubert Syndrome 20 | TMEM231 |
237 | Joubert Syndrome 21 | CSPP1 |
238 | Joubert Syndrome 22 | PDE6D |
239 | Joubert Syndrome 23 | KIAA0586 |
240 | Joubert Syndrome 24 | TCTN2 |
241 | Joubert Syndrome 27 | B9D1 |
242 | Joubert Syndrome 3 | AHI1 |
243 | Joubert Syndrome 4 | NPHP1 |
244 | Joubert Syndrome 5 | CEP290 |
245 | Joubert Syndrome 6 | TMEM67 |
246 | Joubert Syndrome 7 | RPGRIP1L |
247 | Joubert Syndrome 8 | ARL13B |
248 | Joubert Syndrome 9 | CC2D2A |
249 | Juvenile Amyotrophic Lateral Sclerosis 2 | ALS2 |
250 | Juvenile Hemochromatosis, Type 2 | HAMP |
251 | Juvenile Neuronal Ceroid Lipofuscinose | CLN3 |
252 | Juvenile Paget Disease | TNFRSF11B |
253 | Juvenile Retinoschisis | RS1 |
K | ||
254 | Kenny-Caffey Syndrome, Type 1 | TBCE |
255 | Krabbe Disease | GALC |
L | ||
256 | Lamellar Ichthyosis | TGM1 |
257 | Late Infantile Neuronal Ceroid Lipofuscinoses | CLN6 |
258 | Lathosterolosis | SC5D |
259 | Leber Congenital Amaurosis 16 | KCNJ13 |
260 | Leber Congenital Amaurosis 2 | RPE65 |
261 | Leprechaunism | INSR |
262 | Lethal Congenital Contracture Syndrome 1 | GLE1 |
263 | Lethal Congenital Contracture Syndrome 2 | ERBB3 |
264 | Lethal Osteosclerotic Bone Dysplasia | FAM20C |
265 | Leukoencephalopathy with Vanishing White Matter | EIF2B5 |
266 | Limb-Girdle Muscular Dystrophy, Type 1 | CAPN3 |
267 | Limb-Girdle Muscular Dystrophy, Type 17 | PLEC |
268 | Limb-Girdle Muscular Dystrophy, Type 2 | DYSF |
269 | Limb-Girdle Muscular Dystrophy, Type 23 | LAMA2 |
270 | Limb-Girdle Muscular Dystrophy, Type 3 | SGCA |
271 | Limb-Girdle Muscular Dystrophy, Type 4 | SGCB |
272 | Limb-Girdle Muscular Dystrophy, Type 5 | SGCG |
273 | Limb-Girdle Muscular Dystrophy, Type 5C | FKRP |
274 | Limb-Girdle Muscular Dystrophy, Type C1 | POMT1 |
275 | Limb-Girdle Muscular Dystrophy, Type C3 | POMGNT1 |
276 | Lipoid Adrenal Hyperplasia | STAR |
277 | Lipoprotein Lipase Deficiency | LPL |
278 | Long-Chain Hydroxyacyl-CoA Dehydrogenase Deficiency | HADHA |
279 | Lysinuric Protein Intolerance | SLC7A7 |
M | ||
280 | Mandibuloacral Dysplasia | ZMPSTE24 |
281 | Maple Syrup Urine Disease, Type III | DLD |
282 | Maple syrup urine Disease, Type 1A | BCKDHA |
283 | Maple syrup urine Disease, Type 1B | BCKDHB |
284 | Maple syrup urine Disease, Type II | DBT |
285 | Marinesco-Sjögren Syndrome | SIL1 |
286 | Medium Chain Acyl-CoA Dehydrogenase Deficiency | ACADM |
287 | Megalencephalic Leukoencephalopathy 1 | MLC1 |
288 | Metachromatic Leukodystrophy | ARSA |
289 | Methylmalonic Aciduria, MMAA-Related | MMAA |
290 | Methylmalonic Aciduria, MMAB-Related | MMAB |
291 | Methylmalonic Aciduria, MMACHC-Related | MMACHC |
292 | Methylmalonic Aciduria, MMUT-Related | MMUT |
293 | Mitochondrial Complex I Deficiency, ACAD9-Related | ACAD9 |
294 | Mitochondrial DNA depletion Syndrome 1, TYMP-Related | TYMP |
295 | Mitochondrial Trifunctional Protein Deficiency 2 | HADHB |
296 | Molybdenum Cofactor Deficiency, Type A | MOCS1 |
297 | Mucolipidosis II/IIIA | GNPTAB |
298 | Mucolipidosis III gamma | GNPTG |
299 | Mucolipidosis, Type IV | MCOLN1 |
300 | Mucopolysaccharidosis, Type IVB | GLB1 |
301 | Mucopolysaccharidosis, Type IX | HYAL1 |
302 | Mucopolysaccharidosis, Type VI | ARSB |
303 | Mucopolysaccharidosis, Type VII | GUSB |
304 | Mulibrey Nanism | TRIM37 |
305 | Multiple Pterygium Syndrome | CHRNA1 |
306 | Multiple Sulfatase Deficiency | SUMF1 |
307 | Myasthenic Syndrome 13 | DPAGT1 |
308 | Myasthenic Syndrome 22 | PREPL |
309 | Myoclonic Epilepsy of Lafora, Type 2A | EPM2A |
310 | Myoclonic Epilepsy of Lafora, Type 2B | NHLRC1 |
311 | Myoclonic Epilepsy of Unverricht and Lundborg, Type 1A | CSTB |
312 | Myophosphorylase Deficiency | PYGM |
N | ||
313 | N-Acetylglutamate Synthase Deficiency | NAGS |
314 | Nemaline Myopathy 2 | NEB |
315 | Nemaline Myopathy 5 | TNNT1 |
316 | Neonatal Glycine Encephalopathy | AMT |
317 | Neonatal Glycine Encephalopathy | GCSH |
318 | Neonatal Ichthyosis-Sclerosing Cholangitis | CLDN1 |
319 | Nephronophthisis 3 | NPHP3 |
320 | Nephrotic Syndrome, Type 1 | NPHS1 |
321 | Nephrotic Syndrome, Type 2 | NPHS2 |
322 | Neuronal ceroid lipofuscinosis, PPT1-Related | PPT1 |
323 | Neuronal ceroid lipofuscinosis, TPP1-Related | TPP1 |
324 | Neuronal ceroid-lipofuscinosis, CLN5-Related | CLN5 |
325 | Neutropenia, Severe congenital 3 | HAX1 |
326 | Neutropenia, Severe congenital 4 | G6PC3 |
327 | Niemann-Pick Disease | SMPD1 |
328 | Niemann-Pick Disease, Type C1 | NPC1 |
329 | Niemann-pick Disease, Type C2 | NPC2 |
330 | Nijmegen Breakage Syndrome | NBN |
331 | Non-Syndromic Hearing Loss | TMC1 |
332 | Non-Syndromic Hearing Loss, GJB2-Related | GJB2 |
333 | Nonaka Myopathy | GNE |
O | ||
334 | Odontoonychodermal Dysplasia | WNT10A |
335 | Omenn Syndrome | RAG1 |
336 | Omenn Syndrome | DCLRE1C |
337 | Omenn syndrome | RAG2 |
338 | Osteopetrosis | CA2 |
339 | Osteopetrosis, Infantile Malignant | TCIRG1 |
P | ||
340 | Pendred Syndrome | SLC26A4 |
341 | Peroxisomal Acyl-CoA Oxidase Deficiency | ACOX1 |
342 | Peroxisome Biogenesis Disorder | PEX7 |
343 | Perrault Syndrome 1 | HSD17B4 |
344 | Perrault Syndrome 5 | TWNK |
345 | Phenylketonuria | PAH |
346 | Pierson Syndrome | LAMB2 |
347 | Pituitary Hormone Deficiency 2 | PROP1 |
348 | Polycystic Kidney Disease 4 | PKHD1 |
349 | Polyglandular aAutoimmune Syndrome, Type 1 | AIRE |
350 | Polymicrogyria | ADGRG1 |
351 | Polyneuropathy, Hearing Loss, Ataxia, Retinitis Pigmentosa and Cataract, PHARC Disorder | ABHD12 |
352 | Pontocerebellar Hypoplasia, Type 1 | RARS2 |
353 | Pontocerebellar Hypoplasia, Type 2 | TSEN54 |
354 | Postnatal Progressive Microcephaly | MED17 |
355 | Primary Ciliary Dyskinesia, DNAH5-Related | DNAH5 |
356 | Primary congenital glaucoma | CYP1B1 |
357 | Progressive Cerebellocerebral Atrophy, Type 1 | SEPSECS |
358 | Progressive Cerebellocerebral Atrophy, Type 2 | VPS53 |
359 | Progressive Familial Intrahepatic Cholestasis, Type 1 | ATP8B1 |
360 | Progressive Familial Intrahepatic Cholestasis, Type 2 | ABCB11 |
361 | Propionicacidemia | PCCA |
362 | Propionicacidemia | PCCB |
363 | Pseudohypoaldosteronism, Type IB | SCNN1B |
364 | Pseudohypoaldosteronism, Type IB1 | SCNN1A |
365 | Pseudohypoaldosteronism, Type IB3 | SCNN1G |
366 | Pycnodysostosis | CTSK |
367 | Pyridoxamine 5'-Phosphate Oxidase Deficiency | PNPO |
368 | Pyruvate Kinase Deficiency | PKLR |
R | ||
369 | Renal Hypomagnesemia 5 | CLDN19 |
370 | Retinitis Pigmentosa 12 | CRB1 |
371 | Retinitis Pigmentosa 25 | EYS |
372 | Retinitis Pigmentosa 26 | CERKL |
373 | Retinitis Pigmentosa 28 | FAM161A |
374 | Retinitis Pigmentosa 59 | DHDDS |
375 | Rhizomelic Chondrodysplasia Punctata, Type 3 | AGPS |
376 | Roberts Syndrome | ESCO2 |
S | ||
377 | Salla Disease | SLC17A5 |
378 | Sandhoff Disease | HEXB |
379 | Sanfilippo Syndrome A | SGSH |
380 | Sanfilippo Syndrome B | NAGLU |
381 | Sanfilippo Syndrome C | HGSNAT |
382 | Schimke Immunoosseous Dysplasia | SMARCAL1 |
383 | Schneckenbecken Dysplasia | SLC35D1 |
384 | Schwartz-Jampel Syndrome, Type 1 | HSPG2 |
385 | Seckel Syndrome | ATR |
386 | Senior-Loken Syndrome 4 | NPHP4 |
387 | Senior-Loken Syndrome 5 | IQCB1 |
388 | Short-Chain Acyl-CoA Dehydrogenase Deficiency | ACADS |
389 | Short-Rib Thoracic Dysplasia | TTC21B |
390 | Shwachman-Diamond Syndrome | SBDS |
391 | Sialidosis, Type I | NEU1 |
392 | Sjogren-Larsson Syndrome | ALDH3A2 |
393 | Skin Fragility-Woolly Hair Syndrome | DSP |
394 | Smith-Lemli-Opitz Syndrome | DHCR7 |
395 | Spastic Ataxia of Charlevoix-Saguenay | SACS |
396 | Spinal Muscular Atrophy | SMN1 |
397 | Spinal Muscular Atrophy Type 2 | SMN2 |
398 | Stargardt Disease 1 | ABCA4 |
399 | Steel Syndrome | COL27A1 |
400 | Stuve-Wiedemann Syndrome / Schwartz-Jampel Syndrome, Type 2 | LIFR |
401 | Succinate-CoA Ligase Deficiency | SUCLA2 |
402 | Sudden infant death with dysgenesis of the testes Syndrome | TSPYL1 |
403 | Sulfite Oxidase Deficiency | SUOX |
T | ||
404 | T-cell immunodeficiency, Congenital Alopecia and Nail Dystrophy | FOXN1 |
405 | Tay-Sachs Disease | HEXA |
406 | Tetra-Amelia Syndrome 1 | WNT3 |
407 | Tyrosinemia, Type I | FAH |
U | ||
408 | Usher Syndrome, Type 1 | USH1G |
409 | Usher Syndrome, Type 1B | MYO7A |
410 | Usher Syndrome, Type 1C | USH1C |
411 | Usher Syndrome, Type 1D | CDH23 |
412 | Usher Syndrome, Type 1F | PCDH15 |
413 | Usher Syndrome, Type 2A | USH2A |
414 | Usher Syndrome, Type 2C | ADGRV1 |
415 | Usher Syndrome, Type 2D | WHRN |
416 | Usher Syndrome, Type 3 | CLRN1 |
417 | Usher Syndrome, Type IJ | CIB2 |
V | ||
418 | Very-long Chain Acyl-CoA Dehydrogenase Deficiency | ACADVL |
419 | Vitamin D-dependent Rickets, Type I | CYP27B1 |
W | ||
420 | Walker-Warburg Syndrome | FKTN |
421 | Warsaw Breakage Syndrome | DDX11 |
422 | Wilson Disease | ATP7B |
423 | Wolcott-Rallison Syndrome | EIF2AK3 |
424 | Wolman Disease | LIPA |
Z | ||
425 | Zellweger spectrum Disorders 1A | PEX1 |
426 | Zellweger spectrum Disorders 4A | PEX6 |
427 | Zellweger spectrum Disorders 5A | PEX2 |
428 | Zellweger spectrum Disorders 6A | PEX10 |